MODULATION OF THROMBOXANE RECEPTOR ACTIVATION IN RAT GLOMERULAR MESANGIAL CELLS

被引:19
作者
SPURNEY, RF [1 ]
MIDDLETON, JP [1 ]
RAYMOND, JR [1 ]
COFFMAN, TM [1 ]
机构
[1] DUKE UNIV, DEPT MED, DURHAM, NC 27710 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1994年 / 267卷 / 03期
关键词
EICOSANOID; PHOSPHOLIPASE C; INOSITOL PHOSPHATE; PROTEIN KINASE C;
D O I
10.1152/ajprenal.1994.267.3.F467
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Rat glomerular mesangial cells were used to investigate mechanisms of thromboxane A(2) (TxA(2)) receptor regulation in the kidney. Exposure of mesangial cells to the TxA(2) agonist U-46619 for 10 min reduced subsequent TxA(2)-induced increases in inositol phosphates and intracellular Ca2+ levels by similar to 70%. This loss of receptor responsiveness could be blocked by the TxA(2) receptor antagonist SQ-29548 and was reversible after removal of agonist from the incubation medium. Radioligand binding studies using the TxA(2) agonist [I-125]BOP suggested that exposure of mesangial cells to U-46619 for 10 min reduced TxA(2) receptor responsiveness without a loss of receptor sites from plasma membrane fractions of the cell, although the density of mesangial cell TxA(2) receptors was decreased by similar to 60% after more prolonged exposure of mesangial cells to thromboxane agonists. Both desensitization to U-46619 and loss of TxA(2) binding sites could be attenuated by the protein kinase C (PKC) inhibitors staurosporine, sphingosine, or H-7, and TxA(2) receptor responsiveness was reduced in cells incubated with phorbol esters before stimulation with thromboxane agonists. We conclude that 1) agonist-specific decreases in TxA(2) receptor responsiveness may involve initial uncoupling of the receptor from its effector systems, followed by a loss of TxA(2) receptor sites from plasma membrane fractions of the cell, and 2) PKC may be involved in these processes.
引用
收藏
页码:F467 / F478
页数:12
相关论文
共 33 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]   ANGIOTENSIN AND THROMBOXANE IN GENETICALLY HYPERTENSIVE RATS - RENAL BLOOD-FLOW AND RECEPTOR STUDIES [J].
CHATZIANTONIOU, C ;
ARENDSHORST, WJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (02) :F238-F247
[3]   COMPARISON OF THE ACTIONS OF U-46619, A PROSTAGLANDIN H2-ANALOGUE, WITH THOSE OF PROSTAGLANDIN-H2 AND THROMBOXANE-A2 ON SOME ISOLATED SMOOTH-MUSCLE PREPARATIONS [J].
COLEMAN, RA ;
HUMPHREY, PPA ;
KENNEDY, I ;
LEVY, GP ;
LUMLEY, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 73 (03) :773-778
[4]   DISTINCT PLATELET THROMBOXANE-A2 PROSTAGLANDIN-H2 RECEPTOR SUBTYPES - A RADIOLIGAND BINDING STUDY OF HUMAN-PLATELETS [J].
DORN, GW .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1883-1891
[5]   REGULATION OF RESPONSE TO THROMBOXANE A2 IN CHRF-288 MEGAKARYOCYTIC CELLS [J].
DORN, GW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (04) :C991-C999
[6]   DIFFERENTIAL MEGAKARYOCYTIC DESENSITIZATION TO PLATELET AGONISTS [J].
DORN, GW ;
DAVIS, MG .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (04) :C864-C872
[7]  
DORN GW, 1991, J PHARMACOL EXP THER, V259, P228
[8]  
FURCI L, 1991, J PHARMACOL EXP THER, V258, P74
[9]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
[10]  
HANNUN YA, 1991, METHOD ENZYMOL, V201, P316